• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高龄患者下肢慢性肢体威胁性缺血的血运重建。

Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.

机构信息

Division of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, CT.

Department of Surgery, Yale School of Medicine, New Haven, CT; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT.

出版信息

Ann Vasc Surg. 2021 Apr;72:517-528. doi: 10.1016/j.avsg.2020.08.135. Epub 2020 Sep 12.

DOI:10.1016/j.avsg.2020.08.135
PMID:32927042
Abstract

BACKGROUND

Patients with chronic limb-threatening ischemia (CLTI) at the extremes of age are thought to have distinct risk factor profiles and poor outcomes after lower extremity revascularization (LER). The aim of this study is to examine the relationships among age, risk factor profiles, and outcomes of LER in patients with CLTI in a large database focusing on the extreme age groups.

METHODS

Patients undergoing LER for CLTI in the Vascular Quality Initiative suprainguinal bypass, infrainguinal bypass, and peripheral vascular intervention files were reviewed through 2019. Patients were stratified into 3 groups: premature peripheral artery disease (PAD) (≤50 years old), 51-84 years old, and elderly (≥85 years old). Trends in major amputation and mortality by age group were analyzed.

RESULTS

There were 156,513 patients who underwent LER for CLTI. Of these, 9,063 (5.79%) patients had premature PAD, 131,694 (84.14%) patients were 51-84 years old, and 15,756 (10.07%) were elderly. Patients with premature PAD were more likely to have insulin-dependent diabetes, be dialysis-dependent, and be active smokers compared to patients 51-84 years old and the elderly. Elderly patients were more likely to undergo an endovascular procedure for tissue loss compared to younger groups. Perioperative and 1-year major amputation rates were highest among patients with premature PAD and decreased with increasing age (P < 0.001), while perioperative and 1-year mortality increased with age (P < 0.001). On multivariable analysis, premature PAD was associated with an increased risk of major amputation (odds ratio, OR = 1.41 [1.22-1.62]), while elderly age was associated with decreased odds of major amputation compared to patients 51-84 years old (OR = 0.61 [0.51-0.73]).

CONCLUSIONS

Patients at the extremes of age have significantly different outcomes after LER for CLTI. Although mortality increases with age, the risk of major amputation decreases. Patients with premature PAD constitute a group of patients with a high risk of perioperative and 1-year major amputation.

摘要

背景

患有慢性肢体威胁性缺血 (CLTI) 的高龄患者被认为具有独特的风险因素特征,并且在下肢血运重建 (LER) 后预后较差。本研究的目的是在一个专注于极端年龄组的大型数据库中检查 CLTI 患者的年龄、风险因素特征与 LER 结果之间的关系。

方法

通过 2019 年,对血管质量倡议腹主动脉旁路术、股动脉旁路术和外周血管介入文件中接受 LER 治疗 CLTI 的患者进行了回顾。患者分为 3 组:早发性外周动脉疾病 (PAD) (≤50 岁)、51-84 岁和老年 (≥85 岁)。分析按年龄组划分的主要截肢和死亡率趋势。

结果

共有 156513 名患者接受了 LER 治疗 CLTI。其中,9063 名 (5.79%)患者为早发性 PAD,131694 名 (84.14%)患者为 51-84 岁,15756 名 (10.07%)为老年患者。与 51-84 岁和老年患者相比,早发性 PAD 患者更可能患有胰岛素依赖型糖尿病、依赖透析和活跃吸烟者。与年轻组相比,老年患者更有可能因组织丧失而行血管内治疗。围手术期和 1 年主要截肢率在早发性 PAD 患者中最高,且随年龄增长而降低 (P<0.001),而围手术期和 1 年死亡率随年龄增长而增加 (P<0.001)。多变量分析显示,早发性 PAD 与主要截肢风险增加相关 (比值比,OR=1.41 [1.22-1.62]),而与 51-84 岁患者相比,高龄与主要截肢风险降低相关 (OR=0.61 [0.51-0.73])。

结论

在接受 LER 治疗 CLTI 的高龄患者中,其结果存在显著差异。尽管死亡率随年龄增长而增加,但主要截肢的风险降低。早发性 PAD 患者构成了一个围手术期和 1 年主要截肢风险较高的患者群体。

相似文献

1
Lower Extremity Revascularization for Chronic Limb-Threatening Ischemia among Patients at the Extremes of Age.高龄患者下肢慢性肢体威胁性缺血的血运重建。
Ann Vasc Surg. 2021 Apr;72:517-528. doi: 10.1016/j.avsg.2020.08.135. Epub 2020 Sep 12.
2
Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.对于因膝下动脉疾病导致慢性肢体威胁性缺血的患者,采用旁路优先与血管内优先策略的临床结果。
J Vasc Surg. 2019 Jan;69(1):156-163.e1. doi: 10.1016/j.jvs.2018.05.244.
3
Major Adverse Limb Events Among Patients with Premature Peripheral Artery Disease Compared with Those at the Common Age Undergoing Revascularization in the Vascular Quality Initiative.血管质量倡议中,与常见年龄接受血运重建的患者相比,外周动脉疾病患者的主要肢体不良事件。
Ann Vasc Surg. 2022 Nov;87:188-197. doi: 10.1016/j.avsg.2022.07.007. Epub 2022 Aug 2.
4
Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.患有晚期外周动脉疾病的活跃吸烟者进行开放性和血管腔内下肢血管重建术的结果。
J Vasc Surg. 2017 Jun;65(6):1680-1689. doi: 10.1016/j.jvs.2017.01.025.
5
Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.有或无既往血运重建的患者行股腘动脉旁路移植术的围手术期结局
J Vasc Surg. 2017 May;65(5):1354-1365.e2. doi: 10.1016/j.jvs.2016.10.114. Epub 2017 Feb 9.
6
Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease.比较慢性肢体威胁性缺血合并伴发慢性肾脏病患者下肢旁路与外周血管介入治疗后的死亡率和截肢率。
J Vasc Surg. 2024 Aug;80(2):480-489.e5. doi: 10.1016/j.jvs.2024.04.016. Epub 2024 Apr 10.
7
Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.下肢动脉疾病初次血运重建策略中旁路和血管内介入治疗的患者选择和围手术期结局。
J Vasc Surg. 2018 Jan;67(1):206-216.e2. doi: 10.1016/j.jvs.2017.05.132. Epub 2017 Aug 24.
8
Anticoagulation in Patients with Premature Peripheral Artery Disease Undergoing Lower Extremity Revascularization.下肢血运重建术治疗的早发性外周动脉疾病患者的抗凝治疗。
Ann Vasc Surg. 2024 Aug;105:150-157. doi: 10.1016/j.avsg.2024.02.006. Epub 2024 Apr 7.
9
Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.下肢血运重建治疗慢性肢体威胁性缺血后双重抗血小板治疗的影响
J Vasc Surg. 2021 Oct;74(4):1327-1334. doi: 10.1016/j.jvs.2021.04.067. Epub 2021 May 20.
10
One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia.严重肢体缺血开放和血管腔内血运重建术后一年再入院情况
Ann Vasc Surg. 2019 Nov;61:25-32.e2. doi: 10.1016/j.avsg.2019.07.003. Epub 2019 Jul 31.

引用本文的文献

1
Efficacy of autologous cell therapy on limb salvage in patients with chronic limb-threatening ischemia: 16-year single-center experience.自体细胞疗法对慢性肢体威胁性缺血患者保肢的疗效:16年单中心经验
Stem Cell Res Ther. 2025 Jul 15;16(1):362. doi: 10.1186/s13287-025-04493-1.
2
Revascularization in Nonagenarians with Chronic Limb-Threatening Ischemia Can Be Effective.对患有慢性肢体威胁性缺血的九旬老人进行血管重建术可能是有效的。
Cardiovasc Intervent Radiol. 2025 Jun 9. doi: 10.1007/s00270-025-04065-z.
3
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI.
慢性肢体威胁性缺血血管重建术后的年龄相关结局:BEST-CLI分析
Circ Cardiovasc Interv. 2025 Jun;18(6):e014833. doi: 10.1161/CIRCINTERVENTIONS.124.014833. Epub 2025 Apr 3.
4
Sex-Related Differences and Factors Associated with Peri-Procedural and 1 Year Mortality in Chronic Limb-Threatening Ischemia Patients from the CLIMATE Italian Registry.来自意大利CLIMATE注册研究的慢性肢体威胁性缺血患者围手术期及1年死亡率的性别差异和相关因素
J Pers Med. 2023 Feb 11;13(2):316. doi: 10.3390/jpm13020316.
5
Development and validation of a prediction model for the prolonged length of stay in Chinese patients with lower extremity atherosclerotic disease: a retrospective study.开发并验证中国下肢动脉粥样硬化疾病患者住院时间延长的预测模型:一项回顾性研究。
BMJ Open. 2023 Feb 9;13(2):e069437. doi: 10.1136/bmjopen-2022-069437.